tradingkey.logo

Wegovy® (Semaglutide Injection) Receives Conditional Marketing Authorization From Health Canada \

ReutersDec 15, 2025 12:22 PM

-

  • WEGOVY® (SEMAGLUTIDE INJECTION) RECEIVES CONDITIONAL MARKETING AUTHORIZATION FROM HEALTH CANADA AS THE FIRST AND ONLY TREATMENT FOR ADULTS WITH NON-CIRRHOTIC MASH, A SERIOUS LIVER DISEASE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI